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Precision Medicine in Lifestyle
Medicine: The Way of the Future?
Abstract: Precision medicine has
captured the imagination of the
medical community with visions of
therapies precisely targeted to the
specific individual’s genetic, biological,
social, and environmental profile.
However, in practice it has become
synonymous with genomic medicine.
As such its successes have been limited,
with poor predictive or clinical value
for the majority of people. It adds little
to lifestyle medicine, other than in
establishing why a healthy lifestyle is
effective in combatting chronic disease.
The challenge of lifestyle medicine
remains getting people to actually
adopt, sustain, and naturalize a
healthy lifestyle, and this will require
an approach that treats the patient as
a person with individual needs and
providing them with suitable types of
support. The future of lifestyle medicine
is holistic and person-centered rather
than technological.
Keywords: precision medicine;
genomics; epigenetics; microbiome;
caloric restriction; genetic risk
score; individual support; social
connectedness

W

hile “precision medicine” has
been described as an approach
that integrates individual
differences in lifestyle, environment, and
biology, in actual practice it is simply a

rebranding of genomic medicine.
Genomics dominates in almost all
research papers pertaining to precision
medicine with the underlying assumption
that, at its root, disease primarily results
from genetics. As we shall see, the use of
the term “precision” is aspirational and
prematurely hopeful rather than
descriptive. Even when the alternative
term “personalized medicine” is used it
primarily refers to determining what
subgroup an individual belongs to rather
than to medicine that considers the
personhood and individuality of the
patient.1

everyone in remaining disease-free and
independent as long as possible? Should
it be technological or holistic and
humanistic?”
Lifestyle medicine has 3 simple goals
for the individual: to remain healthy as
long as possible, to remain independent
as long as possible, and to live as long as
possible. In other words, the 3 things we
are working against are disease,
dependency, and death. Notably, we are
always working against time since the
longer an unhealthy lifestyle is left
unchecked, the shorter the time until one
or more of these 3 possibilities will be

Lifestyle medicine has 3 simple goals
for the individual: to remain healthy
as long as possible, to remain
independent as long as possible,
and to live as long as possible.
Lifestyle medicine, while recognizing
that genes may predispose to various
diseases, nonetheless postulates, based
on overwhelming evidence, that most
chronic disease results from lifestyle
factors. So, the question is, “Should the
future of lifestyle be centered on genetics
or on lifestyle as the core factor for

realized. Ideally, we do not want to
simply increase life span; we want to
increase health span2 and compress
morbidity.3-5
Genomic medicine is still in its infancy
and currently the preponderance of
evidence favors the lifestyle approach.
Thousands of studies demonstrate not
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only that poor lifestyle increases the risk
of chronic disease but that healthy
lifestyle changes can reduce the risk of
chronic disease, in some cases slowing
or even reversing its progression.
There are 3 areas in which precision
medicine could potentially be of value to
lifestyle medicine:
•• Establishing a causal basis for the
known effectiveness of lifestyle
recommendations
•• Earlier identification of risk, with a
motivating effect for adopting lifestyle
changes at an earlier age
•• Individualizing lifestyle
recommendations to deal with
differences in response
How Genomic Medicine
Helps Explain the
Effectiveness of
Lifestyle Medicine
In recent decades, advances in
genomics have helped explain precisely
why lifestyle changes work.
The first discovery was epigenetic
change and gene methylation in the
mid-1970s.6 While it had been earlier
recognized that every human cell
contains the same genetic material, the
question was how cells were able to
differentiate during embryogenesis and
how genes were able to be either
expressed or silenced. This resulted in
the discovery of heritable epigenetic
changes and finally epigenetic changes
as a result of diet and exercise. In turn
this provided insight into how
inflammation and oxidative stress could
affect gene expression and provided a
pathway to underpinning lifestyle
medicine with fundamental science.
Interest in this area has grown
substantially since 2006. We now know
that what is important is the complex
interplay within the whole genome, with
genes being turned on and off in
response to cellular exposures to
chemical gradients and physiological
stressors.7
The second discovery was that of the
human gut biome.8 Although the
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significance of the microbiome was first
suspected in the mid-1980s,9 the advent
of new genomic technologies in the 21st
century made it possible to identify
thousands of distinct species and families
of bacteria populating the human gut.
For the first time it was possible to see
the effects of diet, exercise, and
probiotics on the ecology of the gut and
to see the effect of microbiomic diversity
and composition on risk of chronic
disease, including certain infectious
diseases. Interest in this area has been
rapidly increasing since 2013.
The third discovery was the effect of
various forms of caloric restriction
(CR),10,11 including fasting-mimicking
diets12 and time-restricted feeding,13 on
gene expression,14 on the composition
and function of gut microbiota,15 and
via differential stress response on
cancerous cells.16,17 CR has been found
to have benefits for autophagy induction
(necessary to destroy dysfunctional
cellular components),18-20 which has
potential impacts on increasing healthy
longevity.21,22 Interestingly, aspirin has
been found to display similar features to
CR.23 It has been hypothesized that
moderate intermittent stressors, like CR,
may mobilize body systems to work
more effectively.24 Whereas the benefits
of fasting had been proclaimed for more
than 2000 years, the underlying
mechanisms have only been placed on
a firm scientific footing within the last
10 years.
Paradoxically, these discoveries
diminish the importance of pure genetics
as an explanatory factor in disease.
Epigenetic change and microbiome
composition and function are driven by
diet and physical activity, which along
with CR, are largely a matter of choice
rather than genetic determinism. Studies
of monozygotic twins who are
genetically identical but diseasediscordant have found epigenetic25,26 and
microbiomic differences,27-29 which
strongly suggest that lifestyle and
environment may largely override
genetics, at least for some diseases. Two
further discoveries complicate the
genetic picture: microchimerism and

somatic mosaicism. In microchimerism, a
woman’s body may contain fetal cells
and alien genetic material from her child,
which persist for decades in different
tissues with the potential for both
beneficial and adverse effects.30,31
Somatic mosaicism is the occurrence of
genetically distinct populations of cells
within an individual due primarily to
mutations during embryogenesis and to
mutations during cell division over the
course of a lifetime,32-34 which may
accumulate with ageing.35
In the face of epigenetics,
microbiomics, microchimerism, and
somatic mosaicism, the search for risky
genes for chronic disease, rather than
being a cost-saving fast track to
accelerated medical progress, may
instead turn out to be an expensive blind
alley. As one review of the progress of
genomic medicine put it, “Soccer is the
sport of the future in America . . . and it
always will be.”36 Claims made for
precision medicine, which always appear
to be just over the horizon, may well fall
into the same category.37
While genomic medicine has had some
successes in relation to targeting drugs
and gene therapies for some rare genetic
variants38 and therapies for some
cancers,39 in general the results have
been mixed.40 Even diseases such as
cancers may be 70% to 90% nongenomic in genesis,41,42 which suggests it
would be better to promote prevention
than cure.
Animal experimentation has revealed
effects of diet and activity, and specific
dietary components that also
demonstrably apply to humans. An
extreme case is that of intermittent CR,
which demonstrably increases longevity
in species as diverse as yeast, nematodes,
mice, and humans.43 If human genetic
diversity were a key factor in chronic
disease, animal models would be almost
worthless. Changes in disease patterns
when East Asian or indigenous peoples44
adopt a Western lifestyle, as well as the
increases in chronic diseases since the
second half of the 20th century,45
strongly suggest that chronic disease is
primarily non-genetic in origin.
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The Success of Lifestyle
Medicine in the Absence
of Genetic Information
The theoretical basis of lifestyle
medicine has changed significantly over
the past decade. Cholesterol has reduced
importance as a risk factor for
cardiovascular disease (CVD),46-49 with
more emphasis on chronic
inflammation50,51 (or metaflammation52)
and oxidative stress53 and the interaction
between the two54 (which have been
referred to as oxy-flammation55 or as an
oxidative-inflammatory cascade56) as key
factors in the genesis of chronic diseases
in general and in their complications.57,58
In the context of aging-related disease,
this has been referred to as
“inflammaging.”59-62
What integrates many aspects of a
healthy lifestyle is mitochondrial
dynamics and its relationship with
inflammation, oxidative stress, and
chronic disease.63-65 Poor lifestyle may
cause mitochondrial dysregulation and
dysfunction,66 while exercise67-69 and
caloric restriction70 may improve
mitochondrial function. Mitochondrial
function has also been identified as a
potential target for mitigating the effects
of age-related chronic disease.71,72 It has
been hypothesized that cancers, rather
than being caused by somatic mutation,
may be caused by or promoted by
mitochondrial dysfunction (based in part
on the role of mitochondrial cell
signaling on apoptosis).73-78 If true, this
would help explain how a healthy
lifestyle reduces cancer risk.
Epigenetic mechanisms show that
genes are not destiny. Instead, there is an
interplay between genetic and lifestyle
factors, both prenatal and over the life
course, influencing gene expression and
the potential for a given disease to
become a reality.79 The ecology of the
human gut and the makeup of the
species with which it is populated also
demonstrably play a role in human
health.80 Lifestyle factors mediate the
composition of and changes in gut flora,
which in turn affect the risk of chronic
disease. The microbiome also appears to
be independent of host genetics81 but is

American Journal of Lifestyle Medicine

affected by both diet82,83 and activity,84
independently of one another.85
Last, there is now greater emphasis on
activity generally rather than just
exercise as a key factor in maintaining a
lifetime of health, with a role in reducing
oxidative stress.86,87 Physical inactivity
has been linked to multiple chronic
diseases including coronary artery
disease, type 2 diabetes (T2D), various
cancers, mental illness, and
dementia.88-95 Conversely, increasing
physical activity may assist in secondary
prevention or reversal of such diseases96
and reduce mortality in survivors of
breast, bowel, and prostate cancers97 as
well as increase brain volumes and
improve memory in older adults,98
reduce depressive symptoms and the
risk of relapse in depression
sufferers.99-101 The latter is particularly
important given the massive increase in
anti-depressant use in the West and the
association between anti-depressant use
and increased risk of CVD.102 Yet
between 2001 and 2015, physical
inactivity rose from 27% to 37% in
developed countries, placing a further
10% of the population at risk.103
In summary, we now have a more
complex theoretical base for looking at
chronic disease and a clearer perspective
on the relative importance of different
lifestyle factors, much of it derived from
population and clinical studies or cell
and molecular biology, rather than
genetics. One complication in many
studies is that lifestyle behaviors tend to
cluster. People with a healthy diet also
tend to be less likely to smoke and more
likely to be physically active; those with
a less healthy diet and in particular those
who eat the most meat tend to have an
less healthy lifestyle overall.104 A study
that only looks at one lifestyle factor
risks confounding from other
unmeasured lifestyle factors. This in itself
highlights the need for a holistic
approach.
The power of the lifestyle approach is
that despite the changes in how we
explain chronic disease and its
prevention, the theoretical changes have
simply served to reinforce the same
recommendations while providing ever

deeper explanations for their
effectiveness.
Major studies over the past few years
have reinforced existing
recommendations105-107 but also provided
some surprises. A major Canadian
study,108 centered on 4 lifestyle factors
(smoking, alcohol consumption, physical
activity, and diet), found that those who
had a healthy lifestyle in relation to all 4
factors could have a life expectancy up
to 18 years longer than those who scored
poorly on all 4 factors. Most surprisingly,
the reduction in life expectancy as a
result of physical inactivity was just as
high as the reduction from smoking, and
both were twice as high as the effect of
diet with minimal reduction in life
expectancy from excessive alcohol
consumption. A study of the risk factors
for being metabolically obese normalweight,109 using factor analysis, found
not 1 but 2 different dietary approaches
that reduced this risk: a “healthy”
approach (high in fruit, vegetables, and
low-fat dairy) and a “prudent” approach
(high in fish and whole grains, low in
refined grains, sweets, sugars, boiled
potatoes, and cured meats), as well as 2
diets that increased the risk, designated
as “fat, meat, and alcohol” and “coca
cola, hard cheese, and French fries.”
Thus, within the lifestyle paradigm there
is still room for diversity both in how
people stay healthy as well as how they
become chronically ill. Two recent
studies have found that a healthy lifestyle
significantly reduces the risk of CVD and
diabetes for both those who are
genetically at risk and the general
population.110,111
Michael Pollan’s advice, “Eat Food. Not
too much. Mostly Plants,”112 is supported
by a growing body of research.
Predominantly plant-based dietary
patterns, both vegetarian and
Mediterranean, are associated with
increased longevity and significant
reductions in risk of chronic
disease.113-116 Several small studies have
even found evidence that broad-based
intensive interventions, which include
such dietary patterns, may slow and even
reverse various chronic diseases,
including coronary artery disease117-120
171
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and age-related cognitive
impairment.121,122 Community-based
programs that encourage such eating
patterns demonstrably result in
significant reductions in risk factors for
coronary artery disease among program
participants, often within a very short
period of time.123,124 Eating less red meat
significantly reduces risk of type 2
diabetes,125 while predominantly
plant-based eating126,127 may markedly
improve glycemic control, reduce
medication use, and potentially reverse
complications.128-131
Would Knowing Genetic
Risk Make a Difference?
In unpacking this question, there are 3
issues to consider: “knowing,” “risk,” and
“make a difference.”
On the question of “knowing,”
genomics produces ambiguous evidence
at best for chronic disease (as opposed
to rare genetic syndromes) and at worst
spurious associations. One example is
the association of over a thousand genes
with educational attainment.132 Social
disadvantage may be associated with
race, so racial differences in gene
frequency could spuriously suggest a
causative association between genes and
education level, health, or economic
achievement. One example of such a
racial difference is the APOE4 gene,
which is found in 25% to 40% of
indigenous people across the world,
while only found in around 12% of
non-indigenous people.133
A core concept in genomics is gene
penetrance, the likelihood that carrying
one or more copies of genes associated
with a disease will actually result in that
disease.134 However, genomic research
involves populations in which the
majority of people lead an unhealthy
lifestyle. Thus, estimates of gene
penetrance are contaminated by the
effects of the gene-lifestyle interaction.135
With as much as 80% of chronic disease
attributable to lifestyle,136 this interaction
is likely to be significant. A large part of
gene penetrance may be explicable
purely in terms of lifestyle and actual
absolute risk from such genetic risks may
172

be grossly overestimated. Genetic risk
may largely be vulnerability to the effects
of an unhealthy lifestyle. Estimates of
gene penetrance also require some
matching between genes and diagnosed
disease; however, the rate of medical
misdiagnosis may be as high as 10% to
15%,137 significantly adding to the
uncertainty of any association found.
Some recent studies suggest that
genetic risk is readily modifiable by
lifestyle change. A large study found that
women who were in the highest decile
for nonmodifiable risk of breast cancer
but who had low BMI, did not drink or
smoke, and did not use menopausal
hormone therapy had risks comparable
to an average woman in the general
population.138 Similarly, individuals in the
top quintile of genetic risk for incident
coronary events who had at least 3 of 4
healthy lifestyle factors (no smoking,
BMI <30, physical activity at least once
weekly, and a healthy diet) had a 46%
lower relative risk of coronary events
compared with those with a less
favorable lifestyle.139 In both cases, even
a moderately healthy lifestyle
significantly reduced genetic risk. A
study of genetic risk versus lifestyle
factors in relation to colorectal cancer
found that lifestyle factors had more
weight than the genetic score.140 Other
studies have further shown that lifestyle
factors account for most of the risk in
relation to CVD.141
A systematic review of the FTO
genotype (a variant related to increased
risk of obesity) and weight loss found
that carriers responded equally well to
weight-loss interventions as
noncarriers.142 Another study, the
DIETFITS study,143 looked at a lowcarbohydrate and a low-fat diet to
identify any difference in outcomes
within groups as a result of genetic
differences or in insulin dynamics. But
the study found that at 12 months there
was no significant difference in outcome
and neither of the potential predisposing
factors could identify which diet was
better for whom.
This sampling of studies demonstrates
that whatever the future may hold in
relation to teasing out gene-disease links,

a healthy lifestyle must still play the
major role in mitigating risk. An
unwarranted emphasis on genetic factors
may simply dilute the message that
taking responsibility for positive lifestyle
behaviors may prevent, delay, or
attenuate most premature disease. It may
focus too much on individual genetic
risk at the expense of the lifestyle risks
that everyone faces.
The second aspect of genetic risk is to
what extent it is a meaningful concept. It
has been estimated that an individual
may carry hundreds of genes associated
with increased risk of various
diseases144,145 for which they will never
display any sign. So, what does it mean
to say that the genes carry a risk? If each
person has a unique genetic profile of
several hundred variants associated with
disease, how could this inform any
clinical decision? Given that most people
are healthy most of the time as are those
around them, to what extent would this
simply undermine genetic risk as a factor
to be considered?146
A person may carry a gene associated
with increased risk for a disease without
any familial history of the disease. They
(and/or their family) may also possess
one or more genes that modify or nullify
the effect of the first gene such that their
risk of that disease is effectively nil.147
Not only genetics but familial patterns of
disease may be important,148 and even
then, the impact of shared lifestyle and
environmental exposures cannot be
dismissed. Complicating matters further,
a SNP (single nucleotide polymorphism)
protecting against one disease may be a
risk factor for another disease.149 The
danger in acting on such perceived risks
is a higher likelihood of overtreatment or
treatment of unclear value,150 carrying
with it risks of its own.
Finally, would knowing genetic risks
make a difference? In many cases, the
answer is no.
Several studies have shown that being
advised of an increased genetic risk does
not result in any significant change in
health behaviors.151,152 Nor does being
diagnosed and treated for
hypertension,153,154 coronary heart
disease,155 type 2 diabetes,156-159 or
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chronic disease generally.155 A study of
college athletes found that being advised
of increased genetic risk of poor
recovery from traumatic brain injury
would not affect their playing
behavior.160
Even surviving cancer makes little
difference to adopting a healthy
lifestyle.161-165 This is of particular
concern given that cancer survivors are
much more likely to suffer from
comorbid chronic disease than the
general population even where their
lifestyle behaviors are the same.166,167
There is growing evidence that cancer
treatments themselves significantly
increase the risk of subsequent
CVD.168,169 Adopting a healthy lifestyle
may increase the likelihood of diseasefree survival170,171 with higher levels of
physical activity reducing the specific
risk of CVD.172,173 The effect of chemoand radiotherapy as cancer treatments on
risk of CVD is itself a warning that
technological approaches to health care
(such as gene therapy) may have
unforeseen adverse health consequences
downstream.
With substantial evidence that knowing
the risk of one disease does not motivate
many people to change their behavior,
what could we then expect of being
advised of genetic risk of a hundred or
more diseases? Would this be motivating,
overwhelming, or simply unbelievable?
Responses are likely to range from
fatalism, panic, and tunnel vision to
incredulity, leading to either inaction or
to overreaction and unnecessary
preemptive treatment. All of these
responses could be dysfunctional,
especially when making healthy lifestyle
changes could provide broad-spectrum
protection against almost all of these
risks.
Carrying a gene that increases risk of
one disease does not reduce risks of
other diseases. A narrow focus on the
one genetic risk may simply shift the risk
to such other diseases instead. A
meta-analysis by the Cochrane
Collaboration on cancer screening found
that “the trials with adequate
randomization did not find an effect of
screening on total cancer mortality,
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including breast cancer, after 10 years . . .
or on all-cause mortality after 13 years.”174
Why Do Not People
Adopt Healthy
Lifestyle Behaviors?
We tend to make unjustified
assumptions about human behavior
including the assumptions that people
are rational/irrational or that all people
need is more information to motivate
change.175 However, we sometimes
overlook the fact that, for many people,
chronic disease has low saliency and low
perceived risk,176,177 both of which may
need to be addressed if healthy lifestyle
is to be promoted. There are at least 4
barriers to healthy people adopting a
healthier lifestyle.
First, for much of its course, chronic
disease is essentially invisible to other
people. We do not know what
medications the people around us may
be taking for a chronic disease, and it is
only when such a disease reaches a
critical point such as requiring dialysis,
or amputation or other surgery, or where
a person visibly deteriorates or needs
mobility or other functional aids that we
actually see evidence of chronic disease.
This may lead many people to
underestimate the risk. In 2014-2015, a
massive 50% of Australians reported
having at least 1 of 8 chronic diseases.178
Yet in the mass media, there is virtual
silence regarding the prevalence such
diseases. Paradoxically, those at highest
risk of chronic disease may perceive
their risk to be low.179
Second, the normalization of obesity
may reduce motivation to do anything
about weight gain.180,181 While
stigmatization of obesity is
counterproductive182 and obese people
may need additional emotional support
for health behavior change,183 the
validation of obesity by movements such
as the “fat acceptance movement”
potentially undermines public health
efforts to combat obesity and its health
consequences, by encouraging
complacency and inaction.
Third, based on age-specific mortality
rates for Australia, 90% of people in

Western countries now live to at least
the age of 65,184 85% to the age of 70,
and 80% to the age of 75. So, while
people are working, they are unlikely to
see significant levels of mortality in
coworkers or their age-cohort and
would tend to associate chronic disease
with aging, without drawing the
connection between morbidity/mortality
and the cumulative effect of lifestyle
behaviors. When age-specific causes of
death are considered for people under
45, the main causes are suicide and
accidents, which in themselves do not
directly relate to factors such as diet or
activity levels.
Finally, the very success of modern
medicine in stabilizing chronic diseases
(without actually curing them) may
reduce the perceived threat. Coupled
with social safety nets for subsidized
health care and disability payments in
many Western countries, reduction in the
perceived risk of unhealthy behaviors
may lead to more rather than less
unhealthy behavior, the so-called “Fence
Paradox,”185 due to the reduced costs
involved to the individual.186 One such
example is HIV prophylaxis and
treatment.187-189
Can Genetic Risk
Actually Be Predicted
With Precision?
A number of recent studies claim to be
able to predict risk of CVD with accuracy
as great as or better than conventional
clinical measures. One study190 generated
a genetic risk score (GRS) based on
49310 SNPs (single nucleotide
polymorphisms); however, when applied
to new data gave inconsistent results for
different populations (Finnish vs British),
with no overlap in 95% confidence
intervals for odds ratios for the 2
populations. A second study191 used 1.7
million genetic variants to generate a
genetic risk score, but only gave a
marginal improvement over clinical
measures. (Interestingly another study
using only 31 variants yielded
comparable accuracy,192 suggesting that
almost all of the 1.7 million variants were
redundant.) Both of the studies using
173
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large numbers of variants appear to have
a number of methodological issues,
including the assumption that including
more variants of lower demonstrated
association with CVD risk will somehow
improve accuracy rather than simply
adding noise.
But the greatest deficit in such studies
is the lack of consideration of the false
negative rate, the false positive rate, or
specificity,193-195 any of which could have
serious consequences196 for those whom
a model predicts of being at high risk.
Such models may result in overtesting,
overdiagnosis, and overtreatment. In the
process, more people will join the ranks
of the “worried well,” anxious about a
disease they will never get, hypervigilant
for any associated symptoms, and
perhaps less alert to symptoms of the
genesis of an actual unrelated disease.
There are already indications that some
genetic associations may be spurious
with the same SNP showing increased
risk in some populations but not
others.197-199 Some researchers argue for a
more rigorous approach to determining
causality200 and a greater focus on
biological mechanisms,201 with one
recent survey even casting doubt on
whether extensive genetic data will ever
be useful for making reliable causal
inferences.202 In many studies, rather
than all of the SNPs being verified as
present, they are imputed algorithmically.
In the UK Biobank of around 500 000
people, used in many studies, around
805 000 genetic markers have been
collected that by imputation are
increased to 95 million variants.203 Such
high levels of imputation raise
reasonable concerns about the results of
such research.
The human genome is incredibly
variable with the 1000 Genomes Project
finding more than 88 million variants in
just 2504 individuals.204 Such vast
numbers of genetic variants or SNPs can
only be accommodated into existing
statistical methods by aggregating them
and then stratifying the aggregated
values, automatically resulting in loss of
information.205 Different genes may
promote heart disease via different
pathways, for example, by increasing
174

endogenous cholesterol or by
moderating lipid metabolism, antiinflammatory processes, or antioxidant
defenses. But the grab-bag approach of
throwing them all into a homogeneous
category means that even if risk is
established from the GRS it provides no
guidance as to how it should be
mitigated and thus has to fall back on
blanket treatments, which could be
ineffective for the gene variant the
individual actually has. Unless the
functional role of a SNP is established
and how that function relates to
increased risk of CVD, it may simply be
a chance artefact of testing thousands or
millions of variants. Extending a
predictive model beyond a few dozen
variants may not result in increased
predictive power.206,207 One study that
looked at the clinically confirmed
severity of coronary artery disease and
genotype data imputed to 2.5 million
SNPs was only able to confirm a single,
already known, locus as a risk for
severity of coronary artery disease.208
Genomic prediction probably will not
markedly improve in the future simply
because the most common variants with
moderate to high association with
chronic disease have already been
identified,209 that is, the low-hanging fruit
have already been picked.210 As Fröhlich
and coauthors state,
The lack of impact on clinical practice
can largely be attributed to insufficient
performance of predictive models,
difficulties to interpret complex model
predictions, and lack of validation via
prospective clinical trials that
demonstrate a clear benefit compared
to the standard of care.211

A recent study, using only 48 SNPs,
identified from genome-wide association
studies, found that GRS and diet were
independently associated with risk of
T2D and concluded that everyone
regardless of genetic risk would benefit
from favorable food choices.212
Identifying increased genetic risk of
CVD, T2D, or cancer would not
significantly change recommendations
for a healthy lifestyle. The massive
increase in chronic disease since the

mid-20th century has been driven, not by
a massive change in the genetic make-up
of the population but by changes in
lifestyle and environmental exposures.
What Is the Future of
Lifestyle Medicine?
Lifestyle medicine ultimately aims to
make a healthy lifestyle the norm rather
than the exception. This means finding
better strategies to promote a healthy
lifestyle, helping individuals adopt and
sustain such a lifestyle, and combatting
the detrimental effects of an obesogenic
environment. The maximum gains to be
made in reducing chronic disease still lie
in a focus on improving health behaviors
for people generally rather than a focus
on outliers, simply because of the high
prevalence of unhealthy lifestyles.
At the risk of seeming Luddite, the
future of lifestyle medicine is humanistic
rather than technological. It needs to
focus on how more people can be
induced to adopt a healthy lifestyle and
how such a lifestyle can be sustained
and become habitual.213 Whereas limited
frequency health behaviors such as
vaccinations and screening are relatively
easy to promote, a healthy lifestyle
requires repeated-occurrence health
behaviors and continued abstention from
unhealthy behaviors across the entire
lifespan,214 a much tougher proposition.
The obesogenic environment is a
continuing, if not rising, problem (with
digital technology a contributor toward
increased obesity).215 An analogous
approach may need to be taken to
unhealthy foods as has been successfully
taken with smoking, including things
such as banning advertising and
promotion of unhealthy foods aimed at
children, increasing sales taxes on
unhealthy food items, or subsidies on
fruit and vegetables to increase their
affordability.216 However, we still need to
make a distinction between the
environment as a stimulus and individual
responsibility for what people do in
response to that stimulus. If individuals
are not ultimately responsible for their
own health behaviors, health promotion
becomes irrelevant. Environmental
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triggers alone do not cause unhealthy
lifestyles. On a more positive note, there
is some evidence that healthy behaviors
may be becoming more prevalent at least
in the Asia-Pacific region (including
Australia and New Zealand).217
Another area on which lifestyle
medicine needs to focus is making better
use of “teachable moments,” particularly
those times where a patient is advised of
a risk or diagnosis218-220 or where they
have been successfully treated but face
increased risk of co-morbidity.
Increasing our effectiveness in helping
individuals sustain healthy behaviors
requires acknowledging the ways in
which they differ in the kinds of
messages that they find sufficiently
persuasive to result in action,221,222 in the
misinformation and misperceptions they
may have,223 in how they differ in their
motivations224 and in their ability to
implement and sustain changes, and in
how their social environment can
support or undermine change.
Lifestyle medicine also needs to more
deeply explore how mental health risks
may be reduced via health behavioral
change.225 This is of increasing concern
given the huge increase in the rate of
anti-depressant use in Western societies.
Finally, we may need to embrace ideas
that have historically been considered to
lie within the ambit of spirituality, with
numerous studies finding positive
associations between religious
participation and physical and mental
health226-228 as well as associations with
particular components of religious
attitudes such as generosity.196,229
Lifestyle medicine’s future may
ultimately lie in individualizing support
so that adopted lifestyle behaviors
become permanent rather than transient.
Individualizing Support

There are several excellent resources
dealing in detail with individualizing
exercise recommendations for chronic
disease.230-234 In addition, Minich and
Bland’s coverage of issues relating to
special dietary considerations is also
wide-ranging.235 So, the issues
concerning physical aspects of lifestyle
will be covered only briefly here,
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followed by further discussion about
personalization of lifestyle medicine in 3
areas: social connectedness,
psychological skills and support, and
basic practical skills.
Exercise and Activity

For physical activity, the most critical
aspect is to start with activities that lie
within the individual’s capabilities but
which serve to extend those capabilities
over time. This is particularly necessary
where individuals suffer from chronic
diseases, which may cause dysfunction at
the cellular level, but which may improve
over time with diet and activity.
Individuals differ in response to exercise
depending on the intensity, frequency,
duration, and modality, as well as on the
timing and composition of meals,236 so
exercise needs to be tailored to the
individual237 to elicit the best response
for that person.238 For some people,
exercise (not activity) may lead to
adverse effects on blood pressure, highdensity lipoprotein cholesterol or other
biomarkers or symptoms239 so a more
gradual approach, with more biometric
monitoring, could be warranted for such
individuals.
There is some evidence of nonresponse
to particular kinds of exercise for some
people,240 which could mean
experimenting to see what works best at
a given time for a given individual at a
particular stage of chronic disease.241-243
Compensatory behavior, such as
increased eating or reduced activity, may
negate any benefits,244-246 so this may
also need to be addressed.
While there is evidence that
personalized exercise prescription may
enhance response,237 at this point the
specific use of genetic information to
inform exercise prescription may be
premature. A 2017 review of genetic
testing for exercise prescription and
injury prevention found that “the
predictive value of such tests is too low
to warrant clinical application.”247 A
systematic review of VO2-max trainability
found that of 97 genes identified as
possible predictors only 13 were
reproduced in more than 2 studies and
that heterogeneity in the studies limited

the conclusions that could be drawn.248
The META-PREDICT study, which
involved developing predictors, based
largely on genetics, for the health
benefits of exercise for individuals
appears to have quietly died following its
final report in 2016.249
Individuals vary considerably in their
affective response to exercise intensity.
Most people have a positive response to
moderate-intensity exercise while having
an aversive response to higher
intensities.250 Additionally, people who
have more positive feelings about
exercise are more likely to engage in
it.250 So for an individual to continue to
want to exercise they need to feel good
as a result of the exercise,251,252 and it
needs to be set at a level that best
balances effectiveness and affective
response, with an initial focus on
increasing enjoyment of physical
activity.253 Taking individual differences
into account is crucial for effective
physical activity interventions.254
Nutrition

The effects of some nutrients may differ
in people with different gene variants,
although the evidence is often mixed.
While increased requirements for certain
micronutrients have been established
beyond doubt for some people (eg,
folate for pregnant women to prevent
neural tube defects and anencephaly),255
most findings that relate genetics to
nutrient requirements find either small
effect sizes or conflicting evidence for
the direction of the effect. For example,
an examination of genetic variations and
zinc requirements256 concluded that “the
data extracted confirmed a connection
between genetics and zinc requirements,
although the direction and magnitude of
the dietary modification for carriers of
specific genotypes could not be defined.”
In 3 studies (all by the same
researchers) of interaction of DHA with
the APOE4 gene (a risk factor for
Alzheimer’s disease [AD]),257 one study
found limited transfer of DHA to
cerebrospinal fluid,258 another study
using a different measurement method
found increased brain-uptake of DHA for
the same gene,259 while a third study
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suggested that high-dose DHA in early
stages of AD dementia could decrease
prevalence in APOE4 carriers.260 Other
studies have found improved cognitive
function with fish oil supplementation
only in APOE4 carriers261 or conversely
no benefit only for APOE4 carriers.262
The bottom line is that we simply do not
know what the interaction is, if any.
One difficulty in linking micronutrients
with chronic disease is that if an
individual has a high-energy, nutrientpoor diet, then, rather than nutritional
deficiency being the cause of the disease
(eg, obesity), both the disease and
nutritional deficiency may be attributable
to diet quality. Accurately measuring
nutrient intake and nutritional needs for
micronutrients for individuals is
extremely challenging,263 so rather than
focusing on specific nutrients, the safest
approach is a varied diet of healthy
foods,264 adjusting for particular food
sensitivities. However, including
unhealthy foods in a varied diet may
actually increase risk of abdominal
obesity and T2D.265
Social Connectedness

Social isolation and loneliness have
been recognized as detrimental to
health for more than 30 years.266
Growing numbers of people report
social isolation or loneliness, while
others experience dysfunctional or
undermining relationships that can also
be detrimental to health or the success
of a lifestyle medicine intervention.267
Negative social experiences correlate
with poorer health behaviors268 while
loneliness tends to be associated with
poorer social skills.269 Conversely,
support from family, friends, or
workmates may all contribute to a
person making and sustaining healthy
lifestyle changes.270 Belonging to a
cohesive, stable, and homogeneous
community may in itself have positive
health benefits (the so-called Roseto
Effect271), something that modernity
seems to have undermined. Blue Zones
notably involve groups who, whether
by reason of ethnicity, isolation, or
religious participation, constitute such
cohesive communities.
176

Addressing social isolation may be a
core factor in improving lifestyle
behaviors, whether this involves helping
people to improve social skills or
facilitating participation in a stable social
group. Face-to-face support groups272
that persist beyond the intervention and
peer mentoring/support (the buddy
system)273-275 may be effective means of
both supporting behavior change and
reducing the negative impact of social
isolation by providing new social ties
and support, other than that of a paid
health professional. They can also be
more cost-effective,276 an important
consideration in an era of skyrocketing
health costs.
Social skills training and opportunities
to practice these growing skills may help
overcome some of the more detrimental
emotional effects of loneliness that for
some underpin dysfunctional health
behaviors. Finally, the health benefits of
volunteering277,278 may in part lie in
increased social contact with less focus
on self and could form part of a lifestyle
intervention for people lacking social
support.
Psychological Factors

Individual psychological differences
may affect their capacity to adopt and
sustain healthy lifestyle behaviors. How
people deal with failure279 may influence
abandonment of health behaviors, and it
is possible that similar strategies for
dealing with relapse could be utilized as
for addiction.280 One possible future
research direction may be how
individuals deal with micro-temporal
factors such as temporal and situational
cues, as well as transient thoughts and
feelings.214 Individuals also differ on
multiple dimensions on how they
approach goal setting and
achievement,281 so finding the best
approach for the individual may be
essential for long-term success. One key
strategy may be planning in advance
how to deal with obstacles or setbacks282
and using implementation intentions,
which has shown promise in terms of
reducing meat consumption283 and
increasing physical activity.284 Individuals
may have chronic diseases as a result of

past self-regulatory failure and may need
training in a range of skills such as
planning, mental contrasting, distracting,
and reframing.285 Motivational
interviewing and health coaching have
proven effective in assisting individuals
in meeting their health goals286-288 and
may help individuals build self-efficacy.
For individuals with multiple
comorbidities, regimen factors,289 burden
of treatment,290 and patient capacity291
may all need to be considered in
deciding what approach to take with
promoting lifestyle changes for
individuals who may already be
struggling to cope. An approach known
as “minimally disruptive medicine” may
be needed.292 In some cases,
implementing small changes may be the
best approach to take293 with a focus on
progress rather than perfection.
Skills Training

For many individuals, just knowing
what they should be eating is not
enough, they need to be given the skills
to put those recommendations into
practice. In order to be able to eat
healthily, an individual may need to learn
basic cooking and shopping skills and
strategies. Teaching basic cooking skills
has been shown to encourage healthy
eating,294-297 with home-cooked meals
associated with better dietary quality.298
Community interventions to improve
cooking skills have been shown to
increase food literacy,299 while
incorporating cooking demonstrations
and opportunities to taste healthier foods
as part of a health promotion program
could help encourage healthier eating.300
Using a grocery list when shopping is
also associated with a healthier diet
among high risk adults301 and healthy
shopping tours are being increasingly
offered by health organizations.
Conclusion
Precision or genomic medicine is not
the enemy.302 There may be some scope
for cross-fertilization between the 2
specializations. For individuals who
conscientiously adopt a healthy lifestyle
but show no improvement in biomarkers,
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genetic research could help identify
whether there is a genetic explanation or
whether there is some previously
unknown lifestyle or environmental
factor that needs to be considered.
Conversely longitudinal research on
populations who live a healthy lifestyle
could help sharpen estimates of gene
penetrance paving the way to better
predictive models. Such research could
possibly even help identify new lifestyle
factors by looking at differences in
outcome between genetically similar
people following the same healthy
lifestyle.
However, chronic disease is simply not
the primary target for a genetic
approach and extending it to the broad
mass of people at low genetic risk is
overkill. Precision medicine is best
targeted at gene therapy for gene
variants with proven etiology, identifying
genetic factors in variations in drug
effectiveness and identifying high
penetrance genes for disease
screening.209 Primary genetic research
may also identify links between diseases
and the functions of genes and gene
networks that may lead to novel insights
into the genesis of disease.303,304
While this article has identified
technical barriers to a genuinely
“precision” medicine, there are also
numerous ethical issues305-307 and
regulatory protections that would need
to be ironed out should such an
approach become the dominant
paradigm.308 These include things such
as informed consent, continued
ownership of one’s own genetic
information309 and the right to have it
destroyed, privacy (especially in an era
where data leaks are so common and
where depersonalized data can be
re-personalized310), genetic
discrimination, the right to refuse genetic
testing, and the potential for future abuse
by governments.311 Precision medicine
has been described as “drowning in a
regulatory soup.”312 The demand for ever
bigger genomic data sets and ever more
personal medical information with which
to match it, combined with the rush by
governments to accommodate these
demands, is likely to lead to fundamental
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human rights and freedoms being
overridden. There are already calls for
every newborn to be genetically
sequenced313 with the consequent
medicalization of life.
None of these concerns apply to
lifestyle medicine.
We currently seem to be at the “Peak of
Inflated Expectations,”314 and it may be
some years before the limited utility of
precision medicine is recognized and
that projected cost savings are illusory.315
The financial resources being allocated,
for what is effectively a promissory note,
may ultimately divert resources from the
more acute problem: How can we
persuade most people to adopt a healthy
lifestyle?316
Lifestyle medicine now possesses a
much deeper scientific foundation but
the actual recommendations have not
markedly changed as a result. The
fundamental problem for lifestyle
medicine remains: How people can be
motivated to adopt, sustain, and
ultimately naturalize a healthy lifestyle.
Rather than delving ever more deeply
into physical mechanisms, instead we
need to look at the psychological and
social factors that either encourage or
obstruct healthy lifestyle behaviors.
Interventions need to be personalized
to the individual and their embodied
experience of the world. This does not
necessarily mean changing what we
recommend, but it does mean
changing how we support the
individual in their efforts to live
healthier.
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